Literature DB >> 24160828

Prophylactic embolization of the gastroduodenal and right gastric arteries is not routinely necessary before radioembolization with glass microspheres.

Nabeel Hamoui1, Jeet Minocha, Khairuddin Memon, Kent Sato, Robert Ryu, Riad Salem, Robert J Lewandowski.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 24160828     DOI： 10.1016/j.jvir.2013.07.011

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN： 1051-0443            Impact factor:   3.464


× No keyword cloud information.
  10 in total

Review 1.  Planning Arteriography for Yttrium-90 Microsphere Radioembolization.

Authors:  Ron C Gaba
Journal:  Semin Intervent Radiol       Date:  2015-12       Impact factor: 1.513

2.  Clinical and dosimetric considerations for Y90: recommendations from an international multidisciplinary working group.

Authors:  Riad Salem; Siddharth A Padia; Marnix Lam; Jon Bell; Carlo Chiesa; Kirk Fowers; Bonnie Hamilton; Joseph Herman; S Cheenu Kappadath; Thomas Leung; Lorraine Portelance; Daniel Sze; Etienne Garin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-05-16       Impact factor: 9.236

Review 3.  Intra- and Extrahepatic Collaterals: Pitfalls and Pathways for Locoregional Therapy.

Authors:  James Su; Suraj Kapoor; Daniel B Brown
Journal:  Semin Intervent Radiol       Date:  2018-04-05       Impact factor: 1.513

4.  Yttrium-90 radioembolization treatment for unresectable hepatocellular carcinoma: a single-centre prognostic factors analysis.

Authors:  C Floridi; F Pesapane; S A Angileri; D De Palma; F Fontana; F Caspani; A Barile; A Del Sole; C Masciocchi; G Lucignani; G Carrafiello
Journal:  Med Oncol       Date:  2017-09-05       Impact factor: 3.064

5.  Clinical, dosimetric, and reporting considerations for Y-90 glass microspheres in hepatocellular carcinoma: updated 2022 recommendations from an international multidisciplinary working group.

Authors:  Riad Salem; Siddharth A Padia; Marnix Lam; Carlo Chiesa; Paul Haste; Bruno Sangro; Beau Toskich; Kirk Fowers; Joseph M Herman; S Cheenu Kappadath; Thomas Leung; Daniel Y Sze; Edward Kim; Etienne Garin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-09-17       Impact factor: 10.057

Review 6.  Current Approach to Planning Angiography and MAA Administration.

Authors:  Clayton W Commander; David M Mauro
Journal:  Semin Intervent Radiol       Date:  2021-10-07       Impact factor: 1.780

7.  Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma.

Authors:  Riad Salem; Andrew C Gordon; Samdeep Mouli; Ryan Hickey; Joseph Kallini; Ahmed Gabr; Mary F Mulcahy; Talia Baker; Michael Abecassis; Frank H Miller; Vahid Yaghmai; Kent Sato; Kush Desai; Bartley Thornburg; Al B Benson; Alfred Rademaker; Daniel Ganger; Laura Kulik; Robert J Lewandowski
Journal:  Gastroenterology       Date:  2016-08-27       Impact factor: 22.682

Review 8.  Assessment of hepatocellular carcinoma treatment response with LI-RADS: a pictorial review.

Authors:  Nicolas Voizard; Milena Cerny; Anis Assad; Jean-Sébastien Billiard; Damien Olivié; Pierre Perreault; Ania Kielar; Richard K G Do; Takeshi Yokoo; Claude B Sirlin; An Tang
Journal:  Insights Imaging       Date:  2019-12-18

Review 9.  Transarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular Carcinoma.

Authors:  Joseph Ralph Kallini; Ahmed Gabr; Riad Salem; Robert J Lewandowski
Journal:  Adv Ther       Date:  2016-04-02       Impact factor: 3.845

Review 10.  Radioembolization: Is Prophylactic Embolization of Hepaticoenteric Arteries Necessary? A Systematic Review.

Authors:  Alicia S Borggreve; Anadeijda J E M C Landman; Coco M J Vissers; Charlotte D De Jong; Marnix G E H Lam; Evelyn M Monninkhof; Jip F Prince
Journal:  Cardiovasc Intervent Radiol       Date:  2016-03-02       Impact factor: 2.740
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.